accession stringclasses 716
values | cik stringclasses 420
values | company stringclasses 422
values | ticker stringclasses 394
values | filed_date stringdate 2026-07-21 00:00:00 2026-10-19 00:00:00 ⌀ | form stringclasses 1
value | signal stringclasses 12
values | negative bool 2
classes | file_name stringclasses 691
values | url stringlengths 44 98 |
|---|---|---|---|---|---|---|---|---|---|
0001759138-26-000038 | 1759138 | Cabaletta Bio, Inc. | CABA | 2026-08-13 | 8-K | fast_track | false | caba-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1759138/000175913826000038/caba-ex99_1.htm |
0001759138-26-000038 | 1759138 | Cabaletta Bio, Inc. | CABA | 2026-08-13 | 8-K | orphan | false | caba-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1759138/000175913826000038/caba-ex99_1.htm |
0001104659-26-095908 | 1133869 | CAPRICOR THERAPEUTICS, INC. | CAPR | 2026-08-13 | 8-K | topline | false | capr-20260813xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1133869/000110465926095908/capr-20260813xex99d1.htm |
0001104659-26-095908 | 1133869 | CAPRICOR THERAPEUTICS, INC. | CAPR | 2026-08-13 | 8-K | orphan | false | capr-20260813xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1133869/000110465926095908/capr-20260813xex99d1.htm |
0001104659-26-095908 | 1133869 | CAPRICOR THERAPEUTICS, INC. | CAPR | 2026-08-13 | 8-K | pdufa | false | capr-20260813xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1133869/000110465926095908/capr-20260813xex99d1.htm |
0001493152-26-037610 | 1858685 | Biofrontera Inc. | null | 2026-08-13 | 8-K | pdufa | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1858685/000149315226037610/ex99-1.htm |
0001193125-26-349482 | 2093101 | Atrium Therapeutics, Inc. | RNA | 2026-08-13 | 8-K | ind | false | d149126dex991.htm | https://www.sec.gov/Archives/edgar/data/2093101/000119312526349482/d149126dex991.htm |
0001193125-26-349380 | 1671584 | Aptevo Therapeutics Inc. | APVO | 2026-08-13 | 8-K | clinical_hold | true | apvo-ex10_2.htm | https://www.sec.gov/Archives/edgar/data/1671584/000119312526349380/apvo-ex10_2.htm |
0001847367-26-000016 | 1847367 | ALUMIS INC. | ALMS | 2026-08-13 | 8-K | topline | false | alms-20260813xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1847367/000184736726000016/alms-20260813xex99d1.htm |
0000950103-26-012287 | 1771910 | ADC Therapeutics SA | ADCT | 2026-08-13 | 8-K | topline | false | dp251718_ex9901.htm | https://www.sec.gov/Archives/edgar/data/1771910/000095010326012287/dp251718_ex9901.htm |
0000950103-26-012287 | 1771910 | ADC Therapeutics SA | ADCT | 2026-08-13 | 8-K | breakthrough | false | dp251718_ex9901.htm | https://www.sec.gov/Archives/edgar/data/1771910/000095010326012287/dp251718_ex9901.htm |
0001493152-26-037575 | 318306 | ABEONA THERAPEUTICS INC. | ABEO | 2026-08-13 | 8-K | ind | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/318306/000149315226037575/ex99-1.htm |
0001193125-26-349160 | 1650648 | 4D Molecular Therapeutics, Inc. | FDMT | 2026-08-13 | 8-K | topline | false | fdmt-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1650648/000119312526349160/fdmt-ex99_1.htm |
0001193125-26-345753 | 1840233 | Xilio Therapeutics, Inc. | XLO | 2026-08-12 | 8-K | ind | false | xlo-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1840233/000119312526345753/xlo-ex99_1.htm |
0001213900-26-088061 | 1766140 | Unicycive Therapeutics, Inc. | UNCY | 2026-08-12 | 8-K | crl | true | ea030169901ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1766140/000121390026088061/ea030169901ex99-1.htm |
0001213900-26-088061 | 1766140 | Unicycive Therapeutics, Inc. | UNCY | 2026-08-12 | 8-K | orphan | false | ea030169901ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1766140/000121390026088061/ea030169901ex99-1.htm |
0001213900-26-088411 | 2023016 | Turn Therapeutics Inc. | TTRX | 2026-08-12 | 8-K | interim | false | ea030177201ex99-1.htm | https://www.sec.gov/Archives/edgar/data/2023016/000121390026088411/ea030177201ex99-1.htm |
0001193125-26-345732 | 1783328 | TScan Therapeutics, Inc. | TCRX | 2026-08-12 | 8-K | topline | false | tcrx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1783328/000119312526345732/tcrx-ex99_1.htm |
0001193125-26-345874 | 1683553 | SPRUCE BIOSCIENCES, INC. | SPRB | 2026-08-12 | 8-K | breakthrough | false | sprb-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1683553/000119312526345874/sprb-ex99_1.htm |
0001193125-26-345874 | 1683553 | SPRUCE BIOSCIENCES, INC. | SPRB | 2026-08-12 | 8-K | fast_track | false | sprb-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1683553/000119312526345874/sprb-ex99_1.htm |
0001193125-26-345874 | 1683553 | SPRUCE BIOSCIENCES, INC. | SPRB | 2026-08-12 | 8-K | orphan | false | sprb-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1683553/000119312526345874/sprb-ex99_1.htm |
0001193125-26-346894 | 1574094 | RenovoRx, Inc. | RNXT | 2026-08-12 | 8-K | topline | false | rnxt-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1574094/000119312526346894/rnxt-ex99_1.htm |
0001193125-26-346894 | 1574094 | RenovoRx, Inc. | RNXT | 2026-08-12 | 8-K | interim | false | rnxt-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1574094/000119312526346894/rnxt-ex99_1.htm |
0001193125-26-346894 | 1574094 | RenovoRx, Inc. | RNXT | 2026-08-12 | 8-K | orphan | false | rnxt-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1574094/000119312526346894/rnxt-ex99_1.htm |
0001193125-26-346894 | 1574094 | RenovoRx, Inc. | RNXT | 2026-08-12 | 8-K | ind | false | rnxt-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1574094/000119312526346894/rnxt-ex99_1.htm |
0001104659-26-094433 | 1006281 | Protalix BioTherapeutics, Inc. | PLX | 2026-08-12 | 8-K | topline | false | plx-20260812xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1006281/000110465926094433/plx-20260812xex99d1.htm |
0001104659-26-094433 | 1006281 | Protalix BioTherapeutics, Inc. | PLX | 2026-08-12 | 8-K | orphan | false | plx-20260812xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1006281/000110465926094433/plx-20260812xex99d1.htm |
0001104659-26-094848 | 1649989 | Outlook Therapeutics, Inc. | OTLK | 2026-08-12 | 8-K | topline | false | tm2622278d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1649989/000110465926094848/tm2622278d1_ex99-1.htm |
0001104659-26-094848 | 1649989 | Outlook Therapeutics, Inc. | OTLK | 2026-08-12 | 8-K | clinical_hold | true | tm2622278d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1649989/000110465926094848/tm2622278d1_ex99-1.htm |
0001829126-26-008654 | 1979414 | NEONC TECHNOLOGIES HOLDINGS, INC. | NTHI | 2026-08-12 | 8-K | topline | false | neonctechnologies_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1979414/000182912626008654/neonctechnologies_ex99-1.htm |
0001829126-26-008654 | 1979414 | NEONC TECHNOLOGIES HOLDINGS, INC. | NTHI | 2026-08-12 | 8-K | endpoint_met | false | neonctechnologies_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1979414/000182912626008654/neonctechnologies_ex99-1.htm |
0001829126-26-008654 | 1979414 | NEONC TECHNOLOGIES HOLDINGS, INC. | NTHI | 2026-08-12 | 8-K | interim | false | neonctechnologies_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1979414/000182912626008654/neonctechnologies_ex99-2.htm |
0001437749-26-027165 | 1645469 | Monopar Therapeutics | MNPR | 2026-08-12 | 8-K | endpoint_met | false | ex_1003235.htm | https://www.sec.gov/Archives/edgar/data/1645469/000143774926027165/ex_1003235.htm |
0001628280-26-055962 | 1157601 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | 2026-08-12 | 8-K | topline | false | pressrelease-boardappointm.htm | https://www.sec.gov/Archives/edgar/data/1157601/000162828026055962/pressrelease-boardappointm.htm |
0001213900-26-088365 | 1721484 | Longeveron Inc. | LGVN | 2026-08-12 | 8-K | topline | false | ea030175701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1721484/000121390026088365/ea030175701ex99-1.htm |
0001213900-26-088365 | 1721484 | Longeveron Inc. | LGVN | 2026-08-12 | 8-K | fast_track | false | ea030175701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1721484/000121390026088365/ea030175701ex99-1.htm |
0001213900-26-088365 | 1721484 | Longeveron Inc. | LGVN | 2026-08-12 | 8-K | orphan | false | ea030175701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1721484/000121390026088365/ea030175701ex99-1.htm |
0001193125-26-345722 | 1907108 | Lexeo Therapeutics, Inc. | LXEO | 2026-08-12 | 8-K | topline | false | lxeo-ex99_2.htm | https://www.sec.gov/Archives/edgar/data/1907108/000119312526345722/lxeo-ex99_2.htm |
0001193125-26-346856 | 1422143 | Kura Oncology, Inc. | KURA | 2026-08-12 | 8-K | topline | false | kura-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1422143/000119312526346856/kura-ex99_1.htm |
0001193125-26-346856 | 1422143 | Kura Oncology, Inc. | KURA | 2026-08-12 | 8-K | ind | false | kura-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1422143/000119312526346856/kura-ex99_1.htm |
0001193125-26-346919 | 2096997 | Kailera Therapeutics, Inc. | KLRA | 2026-08-12 | 8-K | topline | false | ck0002096997-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2096997/000119312526346919/ck0002096997-ex99_1.htm |
0001055726-26-000024 | 1055726 | INOVIO PHARMACEUTICALS, INC. | INO | 2026-08-12 | 8-K | topline | false | ino-63026x8kex991.htm | https://www.sec.gov/Archives/edgar/data/1055726/000105572626000024/ino-63026x8kex991.htm |
0001055726-26-000024 | 1055726 | INOVIO PHARMACEUTICALS, INC. | INO | 2026-08-12 | 8-K | pdufa | false | ino-63026x8kex991.htm | https://www.sec.gov/Archives/edgar/data/1055726/000105572626000024/ino-63026x8kex991.htm |
0001104659-26-094440 | 1818382 | Humacyte, Inc. | null | 2026-08-12 | 8-K | interim | false | tm2622949d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1818382/000110465926094440/tm2622949d1_ex99-1.htm |
0001104659-26-094440 | 1818382 | Humacyte, Inc. | null | 2026-08-12 | 8-K | fast_track | false | tm2622949d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1818382/000110465926094440/tm2622949d1_ex99-1.htm |
0001193125-26-346908 | 2091349 | First Tracks Biotherapeutics, Inc. | TRAX | 2026-08-12 | 8-K | topline | false | trax-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2091349/000119312526346908/trax-ex99_1.htm |
0001193125-26-346908 | 2091349 | First Tracks Biotherapeutics, Inc. | TRAX | 2026-08-12 | 8-K | fast_track | false | trax-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2091349/000119312526346908/trax-ex99_1.htm |
0001493152-26-037254 | 1326706 | ENvue Medical, Inc. | FEED | 2026-08-12 | 8-K | clinical_hold | true | ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1326706/000149315226037254/ex10-1.htm |
0001104659-26-094528 | 1813814 | Definium Therapeutics, Inc. | DFTX | 2026-08-12 | 8-K | topline | false | tm2622948d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1813814/000110465926094528/tm2622948d1_ex99-2.htm |
0001104659-26-094528 | 1813814 | Definium Therapeutics, Inc. | DFTX | 2026-08-12 | 8-K | endpoint_met | false | tm2622948d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1813814/000110465926094528/tm2622948d1_ex99-1.htm |
0001104659-26-094528 | 1813814 | Definium Therapeutics, Inc. | DFTX | 2026-08-12 | 8-K | interim | false | tm2622948d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1813814/000110465926094528/tm2622948d1_ex99-2.htm |
0001104659-26-094528 | 1813814 | Definium Therapeutics, Inc. | DFTX | 2026-08-12 | 8-K | breakthrough | false | tm2622948d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1813814/000110465926094528/tm2622948d1_ex99-1.htm |
0001835268-26-000027 | 1835268 | Connect Biopharma Holdings Ltd | CNTB | 2026-08-12 | 8-K | topline | false | cntbq22026earningsrelease.htm | https://www.sec.gov/Archives/edgar/data/1835268/000183526826000027/cntbq22026earningsrelease.htm |
0001835268-26-000027 | 1835268 | Connect Biopharma Holdings Ltd | CNTB | 2026-08-12 | 8-K | interim | false | cntbq22026earningsrelease.htm | https://www.sec.gov/Archives/edgar/data/1835268/000183526826000027/cntbq22026earningsrelease.htm |
0001104659-26-094445 | 1509745 | CYPHERPUNK TECHNOLOGIES INC. | CYPH | 2026-08-12 | 8-K | fast_track | false | tm2622925d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1509745/000110465926094445/tm2622925d1_ex99-1.htm |
0001213900-26-088068 | 1851484 | CITIUS ONCOLOGY, INC. | CTOR | 2026-08-12 | 8-K | orphan | false | ea030145601ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1851484/000121390026088068/ea030145601ex99-1.htm |
0001701478-26-000039 | 1701478 | Azitra, Inc. | AZTR | 2026-08-12 | 8-K | topline | false | aztrpressrelease6302026-ex.htm | https://www.sec.gov/Archives/edgar/data/1701478/000170147826000039/aztrpressrelease6302026-ex.htm |
0001701478-26-000039 | 1701478 | Azitra, Inc. | AZTR | 2026-08-12 | 8-K | fast_track | false | aztrpressrelease6302026-ex.htm | https://www.sec.gov/Archives/edgar/data/1701478/000170147826000039/aztrpressrelease6302026-ex.htm |
0001193125-26-345807 | 1540171 | Avalyn Pharma Inc. | AVLN | 2026-08-12 | 8-K | topline | false | ck0001540171-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1540171/000119312526345807/ck0001540171-ex99_1.htm |
0001193125-26-346888 | 1593899 | Atea Pharmaceuticals, Inc. | AVIR | 2026-08-12 | 8-K | topline | false | d165663dex991.htm | https://www.sec.gov/Archives/edgar/data/1593899/000119312526346888/d165663dex991.htm |
0001193125-26-346857 | 1604464 | Atara Biotherapeutics, Inc. | ATRA | 2026-08-12 | 8-K | crl | true | atra-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1604464/000119312526346857/atra-ex99_1.htm |
0001104659-26-094869 | 1868279 | ArriVent BioPharma, Inc. | AVBP | 2026-08-12 | 8-K | topline | false | tm2622880d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1868279/000110465926094869/tm2622880d1_ex99-1.htm |
0001104659-26-094869 | 1868279 | ArriVent BioPharma, Inc. | AVBP | 2026-08-12 | 8-K | breakthrough | false | tm2622880d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1868279/000110465926094869/tm2622880d1_ex99-1.htm |
0001104659-26-094869 | 1868279 | ArriVent BioPharma, Inc. | AVBP | 2026-08-12 | 8-K | orphan | false | tm2622880d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1868279/000110465926094869/tm2622880d1_ex99-1.htm |
0001104659-26-094869 | 1868279 | ArriVent BioPharma, Inc. | AVBP | 2026-08-12 | 8-K | ind | false | tm2622880d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1868279/000110465926094869/tm2622880d1_ex99-1.htm |
0001104659-26-094896 | 921114 | Armata Pharmaceuticals, Inc. | ARMP | 2026-08-12 | 8-K | fast_track | false | armp-20260812xex99d1.htm | https://www.sec.gov/Archives/edgar/data/921114/000110465926094896/armp-20260812xex99d1.htm |
0001171843-26-005442 | 1447028 | Arbutus Biopharma Corp | ABUS | 2026-08-12 | 8-K | fast_track | false | exh_991.htm | https://www.sec.gov/Archives/edgar/data/1447028/000117184326005442/exh_991.htm |
0001193125-26-345672 | 1528115 | Annexon, Inc. | ANNX | 2026-08-12 | 8-K | topline | false | d119960dex991.htm | https://www.sec.gov/Archives/edgar/data/1528115/000119312526345672/d119960dex991.htm |
0001193125-26-345672 | 1528115 | Annexon, Inc. | ANNX | 2026-08-12 | 8-K | fast_track | false | d119960dex992.htm | https://www.sec.gov/Archives/edgar/data/1528115/000119312526345672/d119960dex992.htm |
0001999480-26-000022 | 1999480 | Alto Neuroscience, Inc. | ANRO | 2026-08-12 | 8-K | topline | false | exhibit991-earningsrelease.htm | https://www.sec.gov/Archives/edgar/data/1999480/000199948026000022/exhibit991-earningsrelease.htm |
0001999480-26-000022 | 1999480 | Alto Neuroscience, Inc. | ANRO | 2026-08-12 | 8-K | endpoint_met | false | exhibit991-earningsrelease.htm | https://www.sec.gov/Archives/edgar/data/1999480/000199948026000022/exhibit991-earningsrelease.htm |
0001326190-26-000049 | 1326190 | Altimmune, Inc. | ALT | 2026-08-12 | 8-K | topline | false | alt-20260812xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1326190/000132619026000049/alt-20260812xex99d1.htm |
0001326190-26-000049 | 1326190 | Altimmune, Inc. | ALT | 2026-08-12 | 8-K | breakthrough | false | alt-20260812xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1326190/000132619026000049/alt-20260812xex99d1.htm |
0001326190-26-000049 | 1326190 | Altimmune, Inc. | ALT | 2026-08-12 | 8-K | fast_track | false | alt-20260812xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1326190/000132619026000049/alt-20260812xex99d1.htm |
0001193125-26-345901 | 1520262 | Alkermes plc. | ALKS | 2026-08-12 | 8-K | clinical_hold | true | alks-ex10_1.htm | https://www.sec.gov/Archives/edgar/data/1520262/000119312526345901/alks-ex10_1.htm |
0001628280-26-055940 | 1576885 | Acumen Pharmaceuticals, Inc. | ABOS | 2026-08-12 | 8-K | topline | false | abos-20260812xexx991.htm | https://www.sec.gov/Archives/edgar/data/1576885/000162828026055940/abos-20260812xexx991.htm |
0001628280-26-055940 | 1576885 | Acumen Pharmaceuticals, Inc. | ABOS | 2026-08-12 | 8-K | fast_track | false | abos-20260812xexx991.htm | https://www.sec.gov/Archives/edgar/data/1576885/000162828026055940/abos-20260812xexx991.htm |
0001193125-26-346859 | 1781174 | Acrivon Therapeutics, Inc. | ACRV | 2026-08-12 | 8-K | interim | false | acrv-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1781174/000119312526346859/acrv-ex99_1.htm |
0001193125-26-346859 | 1781174 | Acrivon Therapeutics, Inc. | ACRV | 2026-08-12 | 8-K | fast_track | false | acrv-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1781174/000119312526346859/acrv-ex99_1.htm |
0001855644-26-000007 | 1855644 | Zura Bio Ltd | ZURA | 2026-08-11 | 8-K | topline | false | zura-20260811xex991.htm | https://www.sec.gov/Archives/edgar/data/1855644/000185564426000007/zura-20260811xex991.htm |
0001855644-26-000007 | 1855644 | Zura Bio Ltd | ZURA | 2026-08-11 | 8-K | endpoint_met | false | corporatedeck_zurabiox11.htm | https://www.sec.gov/Archives/edgar/data/1855644/000185564426000007/corporatedeck_zurabiox11.htm |
0001827635-26-000028 | 1827635 | Veradermics, Inc | MANE | 2026-08-11 | 8-K | topline | false | ex991q226earnings.htm | https://www.sec.gov/Archives/edgar/data/1827635/000182763526000028/ex991q226earnings.htm |
0001104659-26-093782 | 894158 | Theriva Biologics, Inc. | TOVX | 2026-08-11 | 8-K | orphan | false | tm2622636d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/894158/000110465926093782/tm2622636d1_ex99-1.htm |
0001193125-26-344594 | 1806310 | Taysha Gene Therapies, Inc. | TSHA | 2026-08-11 | 8-K | topline | false | d161230dex991.htm | https://www.sec.gov/Archives/edgar/data/1806310/000119312526344594/d161230dex991.htm |
0001193125-26-344594 | 1806310 | Taysha Gene Therapies, Inc. | TSHA | 2026-08-11 | 8-K | interim | false | d161230dex991.htm | https://www.sec.gov/Archives/edgar/data/1806310/000119312526344594/d161230dex991.htm |
0001193125-26-344594 | 1806310 | Taysha Gene Therapies, Inc. | TSHA | 2026-08-11 | 8-K | orphan | false | d161230dex991.htm | https://www.sec.gov/Archives/edgar/data/1806310/000119312526344594/d161230dex991.htm |
0001193125-26-343446 | 1400118 | Sagimet Biosciences Inc. | SGMT | 2026-08-11 | 8-K | breakthrough | false | d36435dex992.htm | https://www.sec.gov/Archives/edgar/data/1400118/000119312526343446/d36435dex992.htm |
0001193125-26-343446 | 1400118 | Sagimet Biosciences Inc. | SGMT | 2026-08-11 | 8-K | ind | false | d36435dex992.htm | https://www.sec.gov/Archives/edgar/data/1400118/000119312526343446/d36435dex992.htm |
0001390478-26-000013 | 1390478 | SELLAS Life Sciences Group, Inc. | SLS | 2026-08-11 | 8-K | topline | false | sls-202608118xkexhibit991.htm | https://www.sec.gov/Archives/edgar/data/1390478/000139047826000013/sls-202608118xkexhibit991.htm |
0001213900-26-087506 | 1359931 | Protara Therapeutics, Inc. | TARA | 2026-08-11 | 8-K | breakthrough | false | ea029923601ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1359931/000121390026087506/ea029923601ex99-1.htm |
0001213900-26-087506 | 1359931 | Protara Therapeutics, Inc. | TARA | 2026-08-11 | 8-K | fast_track | false | ea029923601ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1359931/000121390026087506/ea029923601ex99-1.htm |
0001213900-26-087506 | 1359931 | Protara Therapeutics, Inc. | TARA | 2026-08-11 | 8-K | orphan | false | ea029923601ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1359931/000121390026087506/ea029923601ex99-1.htm |
0001193125-26-343469 | 1678660 | Prelude Therapeutics Inc | PRLD | 2026-08-11 | 8-K | ind | false | prld-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1678660/000119312526343469/prld-ex99_1.htm |
0001140361-26-032142 | 1472091 | PDS Biotechnology Corp | PDSB | 2026-08-11 | 8-K | interim | false | ef20079931_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1472091/000114036126032142/ef20079931_ex99-1.htm |
0001404644-26-000056 | 1404644 | Neurogene Inc. | NGNE | 2026-08-11 | 8-K | topline | false | a202608_ngnecorporatepre.htm | https://www.sec.gov/Archives/edgar/data/1404644/000140464426000056/a202608_ngnecorporatepre.htm |
0001404644-26-000056 | 1404644 | Neurogene Inc. | NGNE | 2026-08-11 | 8-K | breakthrough | false | a202608_ngnecorporatepre.htm | https://www.sec.gov/Archives/edgar/data/1404644/000140464426000056/a202608_ngnecorporatepre.htm |
0001933414-26-000112 | 1933414 | Mineralys Therapeutics, Inc. | MLYS | 2026-08-11 | 8-K | pdufa | false | mlys2026q28kex991.htm | https://www.sec.gov/Archives/edgar/data/1933414/000193341426000112/mlys2026q28kex991.htm |
0001193125-26-343482 | 1719714 | Mereo BioPharma Group plc | MREO | 2026-08-11 | 8-K | topline | false | mreo-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1719714/000119312526343482/mreo-ex99_1.htm |
0001193125-26-343519 | 1719714 | Mereo BioPharma Group plc | MREO | 2026-08-11 | 8-K | topline | false | mreo-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1719714/000119312526343519/mreo-ex99_1.htm |
0001193125-26-343482 | 1719714 | Mereo BioPharma Group plc | MREO | 2026-08-11 | 8-K | fast_track | false | mreo-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1719714/000119312526343482/mreo-ex99_1.htm |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.